Thanks...No Problem. I made a second, quite detailed (behaviorally oriented ) Post 18660822 as to my reading of the selling at 68c a weeks ago (from those who had bought below that, an extraordinary feat (of good luck), IMO, if you read it, in addition to the one I mentioned above (those who had bought above, were underwater, and sold at the then support = new resistance, and so, "breaking even"). I tried to outline the thought process, based on the price action. In a nutshell, people sold into (brief) strength.
At the time, SGH had to make a Weekly Close > = 68 (the then resistance, hence the selling, on a huge volume day), and it couldn't. Absent good news, I don't see it happening soon.
Since then the goalposts have moved (down). Now, as I see it, it has to (minimally) retain a Weekly Close above 40 /41, current weekly (support), but others may have a different number. It's the weekly Close that the pros look at first, and then zoom in on the daily.
Cheers
- Forums
- ASX - By Stock
- SGH
- Cliches for days like today
SGH
sgh limited
Add to My Watchlist
1.10%
!
$51.40

Cliches for days like today, page-36
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$51.40 |
Change
-0.570(1.10%) |
Mkt cap ! $20.91B |
Open | High | Low | Value | Volume |
$52.74 | $52.74 | $51.24 | $18.10M | 351.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 245 | $51.20 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$51.46 | 1043 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 245 | 51.200 |
1 | 115 | 51.100 |
1 | 55 | 51.010 |
1 | 98 | 50.850 |
1 | 105 | 50.800 |
Price($) | Vol. | No. |
---|---|---|
51.460 | 600 | 1 |
51.590 | 445 | 1 |
52.050 | 500 | 1 |
52.470 | 258 | 1 |
52.700 | 95 | 1 |
Last trade - 16.10pm 04/07/2025 (20 minute delay) ? |
Featured News
SGH (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
SPONSORED BY The Market Online